162 related articles for article (PubMed ID: 37185699)
1. BCL11A Expression in Breast Cancer.
Kątnik E; Gomułkiewicz A; Piotrowska A; Grzegrzółka J; Rusak A; Kmiecik A; Ratajczak-Wielgomas K; Dzięgiel P
Curr Issues Mol Biol; 2023 Mar; 45(4):2681-2698. PubMed ID: 37185699
[TBL] [Abstract][Full Text] [Related]
2. BCL11A Expression in Non-Small Cell Lung Cancers.
Kątnik E; Gomułkiewicz A; Piotrowska A; Grzegrzółka J; Kmiecik A; Ratajczak-Wielgomas K; Urbaniak A; Glatzel-Plucińska N; Błasiak P; Dzięgiel P
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37372998
[TBL] [Abstract][Full Text] [Related]
3. MiR-137 Suppresses Triple-Negative Breast Cancer Stemness and Tumorigenesis by Perturbing BCL11A-DNMT1 Interaction.
Chen F; Luo N; Hu Y; Li X; Zhang K
Cell Physiol Biochem; 2018; 47(5):2147-2158. PubMed ID: 29975921
[TBL] [Abstract][Full Text] [Related]
4. BCL11A confers cell invasion and migration in androgen receptor-positive triple-negative breast cancer.
Wang X; Xu Y; Xu K; Chen Y; Xiao X; Guan X
Oncol Lett; 2020 Apr; 19(4):2916-2924. PubMed ID: 32218847
[TBL] [Abstract][Full Text] [Related]
5. [Knock-down of BCL11A expression in breast cancer cells promotes MDA-MB-231 cell apoptosis].
Li H; Gui C; Yan L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Nov; 32(11):1532-1535. PubMed ID: 27774950
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of BCL11A expression in ER-negative and PR-negative endometrial carcinoma.
You D; Lin L; Wang Q; Yi T; Zhao L; Li M; Wang P
Int J Clin Exp Pathol; 2018; 11(6):3068-3075. PubMed ID: 31938433
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of BCL11A by siRNA induces apoptosis in B lymphoma cell lines.
Gao Y; Wu H; He D; Hu X; Li Y
Biomed Rep; 2013 Jan; 1(1):47-52. PubMed ID: 24648892
[TBL] [Abstract][Full Text] [Related]
8. BCL11A Is Oncogenic and Predicts Poor Outcomes in Natural Killer/T-Cell Lymphoma.
Shi H; Li C; Feng W; Yue J; Song J; Peng A; Wang H
Front Pharmacol; 2020; 11():820. PubMed ID: 32625084
[TBL] [Abstract][Full Text] [Related]
9. miR‑574‑5p attenuates proliferation, migration and EMT in triple‑negative breast cancer cells by targeting BCL11A and SOX2 to inhibit the SKIL/TAZ/CTGF axis.
Zhang KJ; Hu Y; Luo N; Li X; Chen FY; Yuan JQ; Guo L
Int J Oncol; 2020 May; 56(5):1240-1251. PubMed ID: 32319565
[TBL] [Abstract][Full Text] [Related]
10. Expression and clinical implications of basic leucine zipper ATF-like transcription factor 2 in breast cancer.
Lin Y; Zhou X; Peng W; Wu J; Wu X; Chen Y; Cui Z
BMC Cancer; 2021 Sep; 21(1):1062. PubMed ID: 34565331
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of autophagy as a new means of improving chemotherapy efficiency in high-LC3B triple-negative breast cancers.
Lefort S; Joffre C; Kieffer Y; Givel AM; Bourachot B; Zago G; Bieche I; Dubois T; Meseure D; Vincent-Salomon A; Camonis J; Mechta-Grigoriou F
Autophagy; 2014; 10(12):2122-42. PubMed ID: 25427136
[TBL] [Abstract][Full Text] [Related]
12. The BCL11A-XL expression predicts relapse in squamous cell carcinoma and large cell carcinoma.
Zhang N; Jiang BY; Zhang XC; Xie Z; Su J; Zhang Q; Han JF; Tu HY; Wu YL
J Thorac Dis; 2015 Sep; 7(9):1630-6. PubMed ID: 26543611
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological Significances of Cancer Stem Cell-Associated HHEX Expression in Breast Cancer.
Zhang K; Zhao Q; Li Z; Fu F; Zhang H; Fu J; Zheng M; Zhang S
Front Cell Dev Biol; 2020; 8():605744. PubMed ID: 33425911
[TBL] [Abstract][Full Text] [Related]
14. The expression pattern of Bcl11a, Mdm2 and Pten genes in B-cell acute lymphoblastic leukemia.
Xu L; Wu H; Wu X; Li Y; He D
Asia Pac J Clin Oncol; 2018 Apr; 14(2):e124-e128. PubMed ID: 28544358
[TBL] [Abstract][Full Text] [Related]
15. BCL11A overexpression predicts survival and relapse in non-small cell lung cancer and is modulated by microRNA-30a and gene amplification.
Jiang BY; Zhang XC; Su J; Meng W; Yang XN; Yang JJ; Zhou Q; Chen ZY; Chen ZH; Xie Z; Chen SL; Wu YL
Mol Cancer; 2013 Jun; 12():61. PubMed ID: 23758992
[TBL] [Abstract][Full Text] [Related]
16. Elevated expression of FREM1 in breast cancer indicates favorable prognosis and high-level immune infiltration status.
Li HN; Li XR; Lv ZT; Cai MM; Wang G; Yang ZF
Cancer Med; 2020 Dec; 9(24):9554-9570. PubMed ID: 33058542
[TBL] [Abstract][Full Text] [Related]
17. Correlation between Ki67 and histological grade in breast cancer patients treated with preoperative chemotherapy.
Petric M; Martinez S; Acevedo F; Oddo D; Artigas R; Camus M; Sanchez C
Asian Pac J Cancer Prev; 2014; 15(23):10277-80. PubMed ID: 25556461
[TBL] [Abstract][Full Text] [Related]
18. Expression of BCL11A in chronic lymphocytic leukaemia.
Tosic N; Ugrin M; Marjanovic I; Kostic T; Vukovic V; Tomic K; Otasevic V; Antic D; Mihaljevic B; Pavlovic S; Karan-Djurasevic T
Int J Lab Hematol; 2023 Feb; 45(1):64-71. PubMed ID: 36120992
[TBL] [Abstract][Full Text] [Related]
19. Identification of Seven Cell Cycle-Related Genes with Unfavorable Prognosis and Construction of their TF-miRNA-mRNA regulatory network in Breast Cancer.
Hong Z; Wang Q; Hong C; Liu M; Qiu P; Lin R; Lin X; Chen F; Li Q; Liu L; Wang C; Chen D
J Cancer; 2021; 12(3):740-753. PubMed ID: 33403032
[TBL] [Abstract][Full Text] [Related]
20. Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis.
Wu JR; Zhao Y; Zhou XP; Qin X
Biomed Pharmacother; 2020 Jan; 121():109647. PubMed ID: 31733575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]